Amyloid β-Protein (33-42) (TFA)

This synthetic peptide fragment, corresponding to residues 33-42 of the amyloid-β protein, has been shown to reduce the neurotoxic effects of full-length Aβ42. It serves as a valuable research tool for in vitro and in vivo studies investigating Alzheimer's disease pathology and therapeutic strategies.